STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

February 13, 2026

Period of Report

February 12, 2026

Accession Number

0002064832-26-000014